Acton Pharmaceuticals' Series A - III Round

Acton Pharmaceuticals raised a round of funding on September 17, 2010. Investors include Sequoia Capital.

Acton Pharmaceuticals, is primarily focused on development and commercialization of pharmaceutical products that treat allergic, pulmonary, and other respiratory related diseases.…

Articles about Acton Pharmaceuticals' Series A - III Round: